Today: 21 May 2026
Palantir stock dips today as 2026 trading begins — what traders are watching next for PLTR
2 January 2026
1 min read

Palantir stock dips today as 2026 trading begins — what traders are watching next for PLTR

NEW YORK, January 2, 2026, 10:14 ET — Regular session

  • Palantir shares slipped about 0.4% in mid-morning trading, lagging a broader tech rebound.
  • Investors are weighing lofty valuation metrics as AI-linked stocks trade mixed.
  • Focus is turning to an expected early-February earnings window and updates on commercial AI adoption.

Palantir Technologies (PLTR) shares fell 0.4% to $177.04 on Friday, while the Nasdaq-tracking Invesco QQQ Trust (QQQ) rose about 1.1% in early trade.

The move matters because Palantir has been one of the market’s most closely watched “AI software” names after a sharp 2025 rally, leaving little room for stumbles as investors reset positions for the new year. The Motley Fool

At current levels, the stock remains about 15% below its 52-week high of $207.52, keeping attention on whether momentum returns as the year’s first trading week gets underway.

Broader U.S. stocks were higher, with the SPDR S&P 500 ETF (SPY) up about 0.6% and Nvidia (NVDA) up about 3.0%.

AI-linked software shares were mixed, with Snowflake (SNOW) up about 0.9% and CrowdStrike (CRWD) down about 1.0%.

A recent note from Wedbush’s Dan Ives highlighted what he called “unprecedented” demand for Palantir’s AI platform, even as debate around valuation persists across the group. TipRanks

Palantir sells data-analysis software to government agencies and businesses, and has pushed its Artificial Intelligence Platform, or AIP, as a way for customers to deploy AI models on their own data.

Valuation remains a key fault line. The Motley Fool noted the stock was trading at roughly 435 times trailing earnings and about 188 times forward earnings — based on expected profit — levels that can amplify reactions to growth and margin updates.

The shares traded between $176.54 and $182.93 on Friday, after closing at $177.75 in the prior session.

The next major catalyst is the company’s quarterly report. Palantir has not confirmed its next earnings date, and Wall Street Horizon lists an unconfirmed Feb. 2 after-market slot for results.

Investors will be looking for signs that U.S. commercial demand can sustain recent momentum, alongside any guidance on how quickly AIP deployments translate into durable revenue.

For now, Palantir’s underperformance versus the broader tech rebound underscores a familiar theme: high-multiple AI software stocks can rally hard, but they often require steady execution — and clear visibility — to keep buyers engaged.

Stock Market Today

  • SpaceX Set to Go Public: Key Details and Market Impact
    May 20, 2026, 8:02 PM EDT. SpaceX, founded by Elon Musk, is poised to go public, joining hundreds of companies that raised $70 billion in U.S. equity markets last year. Going public means the company will offer shares for sale on stock exchanges, allowing investors to buy ownership stakes. This move could unlock significant capital for SpaceX's ambitious space ventures, while providing early investors a chance to realize gains. The offering is closely watched amid a strong appetite for tech and aerospace stocks, reflecting broader market interest in innovation-driven firms.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
ASML shares jump after surprise Aletheia upgrade flips outlook on EUV demand
Previous Story

ASML shares jump after surprise Aletheia upgrade flips outlook on EUV demand

IBM’s 2026 quantum milestone puts IonQ and Nvidia back on investors’ radar
Next Story

IBM’s 2026 quantum milestone puts IonQ and Nvidia back on investors’ radar

Go toTop